ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Thursday Apr 04, 2024
Thursday Apr 04, 2024
Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Apr 03, 2024
Pratice Journeys: Happy Not Knowing: Reflections from Pharmacy Residents
Wednesday Apr 03, 2024
Wednesday Apr 03, 2024
Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Apr 02, 2024
Tuesday Apr 02, 2024
4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Mar 28, 2024
Thursday Mar 28, 2024
The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the Impact Wellbeing Guide, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Mar 27, 2024
Wednesday Mar 27, 2024
In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Mar 21, 2024
Thursday Mar 21, 2024
In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Mar 20, 2024
Wednesday Mar 20, 2024
Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Mar 19, 2024
Tuesday Mar 19, 2024
This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Kelley, Christy Norman, and Suzanne Shea will share their insights on their professional journeys as pharmacists and executive leaders and what it means to lead with authenticity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Mar 18, 2024
Monday Mar 18, 2024
Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Mar 15, 2024
Clinical Conversations: SACP: The Skinny on the GLP-1 Agonists (Part 1)
Friday Mar 15, 2024
Friday Mar 15, 2024
Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.